Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ehninger

Showing results (81-90 of 400) with videos related to

Pageof 40
Sort By:
Transplantation|April 1, 1991
Lack of association between the frequencies of HLA-DR or HLA-DP alleles and the occurrence of chronic graft-versus-host diseaseG Pawelec, C Müller, M Haen, et al.
Transplantation|November 1, 1990
8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host diseaseT Eppinger, G Ehninger, M Steinert, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapyG Pawelec, H Schmidt, E Schneider, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipientsH U Krüger, U Schuler, B Proksch, et al.
Mycoses|January 1, 1996
[Disseminated aspergillosis and mucormycosis. A case report]M Mölle, R Blaschke-Hellmessen, U Schuler, et al.
Cancer Research|November 1, 1993
Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediatesK Mewes, J Blanz, G Ehninger, et al.
Cancer Treatment Reports|October 1, 1984
Mitoxantrone and cyclophosphamide in patients with advanced breast cancerG Ehninger, K H Weible, E G Heidemann, et al.
Lancet (London, England)|September 10, 1988
In-situ hybridisation for detection of cytomegalovirus in liver from patients after marrow graftingH Einsele, G Ehninger, A Vallbracht, et al.
Clinical Pharmacokinetics|May 1, 1990
Pharmacokinetics and metabolism of mitoxantrone. A reviewG Ehninger, U Schuler, B Proksch, et al.
Onkologie|December 1, 1990
[Continuous infusion of natural interleukin 2 (n IL-2) in treatment of malignant diseases: phase I study]H J Lenz, T Brunner, R Dopfer, et al.
Pageof 40

Showing results (81-90 of 400) with videos related to

Sort By:
Pageof 40
Transplantation|April 1, 1991
Lack of association between the frequencies of HLA-DR or HLA-DP alleles and the occurrence of chronic graft-versus-host diseaseG Pawelec, C Müller, M Haen, et al.
Transplantation|November 1, 1990
8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host diseaseT Eppinger, G Ehninger, M Steinert, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapyG Pawelec, H Schmidt, E Schneider, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipientsH U Krüger, U Schuler, B Proksch, et al.
Mycoses|January 1, 1996
[Disseminated aspergillosis and mucormycosis. A case report]M Mölle, R Blaschke-Hellmessen, U Schuler, et al.
Cancer Research|November 1, 1993
Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediatesK Mewes, J Blanz, G Ehninger, et al.
Cancer Treatment Reports|October 1, 1984
Mitoxantrone and cyclophosphamide in patients with advanced breast cancerG Ehninger, K H Weible, E G Heidemann, et al.
Lancet (London, England)|September 10, 1988
In-situ hybridisation for detection of cytomegalovirus in liver from patients after marrow graftingH Einsele, G Ehninger, A Vallbracht, et al.
Clinical Pharmacokinetics|May 1, 1990
Pharmacokinetics and metabolism of mitoxantrone. A reviewG Ehninger, U Schuler, B Proksch, et al.
Onkologie|December 1, 1990
[Continuous infusion of natural interleukin 2 (n IL-2) in treatment of malignant diseases: phase I study]H J Lenz, T Brunner, R Dopfer, et al.
Pageof 40